![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Lai
Directeur Général chez
METIS TECHBIO CO., LTD.
Fortune : 289 M $ au 30/06/2026
Profil
Dr. Christopher Lai is a Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., a General Manager & Executive Director at Metis Pharmaceuticals and a Chief Executive Officer at METiS Therapeutics, Inc. He is on the Board of Directors at Metis Pharmaceuticals.
Dr. Lai was previously employed as a Chief Technology Officer by AquaFresco, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 111 166 572 ( 10,26% ) | 218 M $ | 30/06/2026 | |
METIS TECHBIO CO., LTD. 36,55% | 13/05/2026 | 36 400 278 ( 36,55% ) | 71 M $ | 30/06/2026 |
Postes actifs de Christopher Lai
| Sociétés | Poste | Début |
|---|---|---|
| METIS TECHBIO CO., LTD. | Directeur Général | 10/01/2020 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Directeur Général | - |
Anciens postes connus de Christopher Lai
| Sociétés | Poste | Fin |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
